GIOSTAR

San Diego, United States Founded: 2012 • Age: 14 yrs
Stem cell therapies for degenerative and genetic diseases are developed.
Annual revenue - Latest available
Total funding - 1 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About GIOSTAR

GIOSTAR is a company based in San Diego (United States) founded in 2012. GIOSTAR operates in a competitive market with competitors including Insitro, BridgeBio, GSK, ATAI and Forge Biologics, among others.

  • Headquarter San Diego, United States
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    $100 K (USD), Grant

    Apr 30, 2013

  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of GIOSTAR

Investors in GIOSTAR

GIOSTAR has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Grand Challenges Canada.

All
Institutional
Investor Description Founded Year Domain Location
Technology and business sectors are developed through government-backed initiatives.
Locked Locked Locked
Premium access

Investor details for GIOSTAR

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by GIOSTAR

Investments
Premium access

Investment portfolio details for GIOSTAR

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - GIOSTAR

Premium access

Detailed financials for GIOSTAR

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Giostar Comparisons

GIOSTAR Primary company
Description
Stem cell therapies for degenerative and genetic diseases ar...
Location
San Diego, United States
Founded Year
2012
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for GIOSTAR

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of GIOSTAR

GIOSTAR operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, BridgeBio, GSK, ATAI and Forge Biologics, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
An AI-enabled platform is developed for infectious disease treatment.
Locked Locked Locked
Therapeutics for genetic diseases are developed through targeted interventions.
Locked Locked Locked
Developer of pharmaceuticals and vaccines for various therapeutic areas
Locked Locked Locked
A biopharmaceutical company accelerating innovative mental health treatments.
Locked Locked Locked
Gene therapies for rare diseases are developed to treat patients.
Locked Locked Locked
Gene therapies for rare diseases including retinal dystrophies are developed.
Premium access

Detailed competitors of GIOSTAR

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Giostar

Premium access

Complete news archive for GIOSTAR

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about GIOSTAR

GIOSTAR was founded in 2012 and raised its 1st funding round 1 year after it was founded.

GIOSTAR is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

Developer of stem cell-based therapy for degenerative and genetic diseases. It has developed a technique for the extraction of stem cells from a human body and uses them for autologous and allogeneic stem cells transplant. It claims that it has the ability to treat several immunological diseases and blood-related diseases that include diabetes type I and type II, lupus, multiple sclerosis, Crohns disease, vasculitis, scleroderma, myasthenia gravis, sickle cell anemia, leukemia, lymphoma, thalassemia, and developing the therapies for Alzheimers, Autism, Anti-Aging Treatments, Parkinsons disease, Cancer, Heart and Retinal Degeneration and Spinal Muscular Atrophy (SMA).

GIOSTAR's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.

GIOSTAR has 1 investor. Key investors include Grand Challenges Canada.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available